PEGylated Elesclomol@Cu(Ⅱ)-based Metal‒organic framework with effective nanozyme performance and cuproptosis induction efficacy for enhanced PD-L1-based immunotherapy
| Autor: | Lu, Xufeng a, b, c, 1, Deng, Wenhai d, 1, Wang, Shuaibin a, 1, Zhao, Shengsheng a, Zhu, Bingzi a, Bai, Binglong a, Mao, Yiwen e, Lin, Ji b, Yi, Yongdong a, Xie, Zuoliang c, Wang, Xiang a, b, Lu, Yongyong f, Huang, Xiufeng a, You, Tao a, Chen, Xiaolei b, ⁎⁎, Sun, Weijian a, b, ⁎⁎⁎, Shen, Xian a, b, ⁎ |
|---|---|
| Zdroj: | In Materials Today Bio December 2024 29 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|